About Antara, its efficacy, and uses

About
ANTARA®

For the treatment of primary hypercholesterolemia, mixed dyslipidemia, and severe hypertriglyceridemia as adjunctive therapy to diet

ANTARA® provides beneficial effects across key lipid parameters when taken once daily with or without food1

37% reduction in TG
8% reduction in non-HDL-C
14% increase in HDL-C1
Antara provides beneficial effects across key lipid parameters when taken once daily with or without food
Antara reduced TGs by 37% in patients with hypertriglyceridemia & metabolic syndrome Fenofibrate 130mg TRIMS drug study
Enlarge the fenofibrate-coated microgranule study
The 130mg fenofibrate-coated microgranule dose studied is equivalent to a 90mg dose of Antara
References
  1. Davidson MH, Bays H, Rhyne J, et al. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2005;27(6):715-727.
  2. ANTARA® Prescribing Information.